The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
Open accessAbstract
Metastasis of cancer cells is a complex process involving multiple steps including invasion, angiogenesis, and trafficking of cancer cells through blood vessels, extravasations, organ-specific homing, and growth. While matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines play a major role in invasion and angiogenesis, chemokines such as stromal derived factor-1alpha (SDF-1alpha) and their receptors such as CXCR4 are thought to play a critical role in motility, homing, and proliferation of cancer cells at specific metastatic sites. We and others have previously reported that the extracellular signal-activated transcription factor NF-kappaB up-regulates the expression of matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines in highly metastatic breast cancer cell lines. In this report, we demonstrate that NF-kappaB regulates the motility of breast cancer cells by directly up-regulating the expression of CXCR4. Overexpression of the inhibitor of kappaB (IkappaB) in breast cancer cells with constitutive NF-kappaB activity resulted in reduced expression of CXCR4 and a corresponding loss of SDF-1alpha-mediated migration in vitro. Introduction of CXCR4 cDNA into IkappaB-expressing cells restored SDF-1alpha-mediated migration. Electrophoretic mobility shift assays and transient transfection assays revealed that the NF-kappaB subunits p65 and p50 bind directly to sequences within the -66 to +7 region of the CXCR4 promoter and activate transcription. We also show that the cell surface expression of CXCR4 and the SDF-1alpha-mediated migration are enhanced in breast cancer cells isolated from mammary fat pad xenografts compared with parental cells grown in culture. A further increase in CXCR4 cell surface expression and SDF-1alpha-mediated migration was observed with cancer cells that metastasized to the lungs. Taken together, these results implicate NF-kappaB in the migration and the organ-specific homing of metastatic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMD231 cells were obtained from Dr. Harikrishna Nakshatri in 2009 and are a derivative of the MDA-MB-231 cell line (19).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,582
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818
Self-citationBargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 757
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 614
Research works printed but not linked: 8
- Sato, 1993, Oncogene, 8, 395
- Andela, 2000, Cancer Res., 60, 6557
- Dong, 1999, Cancer Res., 59, 3495
- Shattuck-Brandt, 1997, Cancer Res., 57, 3032
- Bachelder, 2002, Cancer Res., 62, 7203
- Koshiba, 2000, Clin. Cancer Res., 6, 3530
- Murakami, 2002, Cancer Res., 62, 7328
- Scotton, 2002, Cancer Res., 62, 5930
Cited by
Sorted by citations
Items 101–200 of 640
Nimmagadda, S., Pullambhatla, M., Stone, K. L., Green, G. M., Bhujwalla, Z. M., & Pomper, M. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4396 · Cited by 137
Sung, B., Jhurani, S., Ahn, K. S., Mastuo, Y., Yi, T., Guha, S., Liu, M., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2155 · Cited by 140
Zhang, J., Peng, B., & Chen, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0241 · Cited by 135
The CXCL12–CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies
Epstein, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1473 · Cited by 134
The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer
Kang, H., Watkins, G., Douglas-Jones, A. G., Mansel, R. E., & Jiang, W. G. (2005) · The Breast · doi:10.1016/j.breast.2004.12.007 · Cited by 133
Shanmugam, M. K., Manu, K. A., Ong, T. H., Ramachandran, L., Surana, R., Bist, P., Lim, L. H. K., Kumar, A. P., Hui, K. M., & Sethi, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26120 · Cited by 134
Chemokine Networks and Breast Cancer Metastasis
Karnoub, A. E., & Weinberg, R. A. (2007) · Breast Disease · doi:10.3233/bd-2007-26107 · Cited by 135
Yan, M., Xu, Q., Zhang, P., Zhou, X., Zhang, Z., & Chen, W. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-437 · Cited by 128
Chen, D., Bhat‐Nakshatri, P., Goswami, C. P., Badve, S., & Nakshatri, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1080 · Cited by 130
Self-citationCytokines, NF-κB, Microenvironment, Intestinal Inflammation and Cancer
Schottelius, A. J. G., & Dinter, H. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_3 · Cited by 129
COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion
van de Sluis, B., Mao, X., Zhai, Y., Groot, A. J., Vermeulen, J. F., van der Wall, E., van Diest, P. J., Hofker, M. H., Wijmenga, C., Klomp, L. W. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40583 · Cited by 132
SLITs Suppress Tumor Growth In vivo by Silencing Sdf1/Cxcr4 within Breast Epithelium
Marlow, R., Strickland, P. A., Lee, J. S., Wu, X., PeBenito, M., Binnewies, M., Le, E. K., Moran, A., Macias, H., Cardiff, R. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1357 · Cited by 136
Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line
Yodkeeree, S., Ampasavate, C., Sung, B., Aggarwal, B. B., & Limtrakul, P. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.052 · Cited by 125
Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer
Srirangam, A., Mitra, R., Wang, M., Gorski, J. C., Badve, S., Baldridge, L., Hamilton, J., Kishimoto, H., Hawes, J. W., Li, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1167 · Cited by 126
Self-citationMechanical Control of Epithelial-to-Mesenchymal Transitions in Development and Cancer
Przybyla, L., Muncie, J. M., & Weaver, V. M. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125150 · Cited by 123
Castellone, M. D., Guarino, V., Falco, V. D., Carlomagno, F., Basolo, F., Faviana, P., Kruhøffer, M., Orntoft, T. F., Russell, J. P., Rothstein, J. L., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207790 · Cited by 125
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis
Schlezinger, J. J., Liu, D., Farago, M., Seldin, D. C., Belguise, K., Sonenshein, G. E., & Sherr, D. H. (2006) · Biological Chemistry · doi:10.1515/bc.2006.145 · Cited by 122
The role of chemokines and their receptors in angiogenesis
Kiefer, F., & Siekmann, A. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0677-7 · Cited by 130
Role of NF-κB in thyroid cancer
Pacifico, F., & Leonardi, A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.10.010 · Cited by 124
Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22
Patel, J. B., Appaiah, H. N., Burnett, R. M., Bhat‐Nakshatri, P., Wang, G., Mehta, R. J., Badve, S., Thomson, M. J., Hammond, S. M., Steeg, P. S., et al. (2010) · Oncogene · doi:10.1038/onc.2010.510 · Cited by 123
Self-citationShishodia, S., & Aggarwal, B. B. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7847-1_8 · Cited by 121
Manu, K. A., Shanmugam, M. K., Rajendran, P., Li, F., Ramachandran, L., Hay, H. S., Kannaiyan, R., Swamy, S. N., Vali, S., Kapoor, S., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-107 · Cited by 126
Chou, R., Hsieh, S.-C., Yu, Y., Huang, M., Huang, Y., & Hsieh, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071983 · Cited by 121
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
Conley‐LaComb, M. K., Semaan, L., Singareddy, R., 李彦锋, Heath, E. I., Kim, S., Cher, M. L., & Chinni, S. R. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0552-0 · Cited by 129
Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
Hinton, C. V., Avraham, S., & Avraham, H. K. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9210-2 · Cited by 119
Falco, V. D., Guarino, V., Avilla, E., Castellone, M. D., Salerno, P., Salvatore, G., Faviana, P., Basolo, F., Santoro, M. M., & Melillo, R. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0899 · Cited by 119
García-Rivera, D., Delgado, R., Bougarne, N., Haegeman, G., & Vanden Berghe, W. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.011 · Cited by 142
Fukuda, S., Broxmeyer, H. E., & Pelus, L. M. (2004) · Blood · doi:10.1182/blood-2004-04-1440 · Cited by 117
Self-citationMaru, S., Holloway, K., Flynn, G., Lancashire, C. L., Loughlin, J., Male, D. K., & Romero, I. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.029 · Cited by 121
Pellegrino, L., Stebbing, J., Braga, V. M. M., Frampton, A. E., Jacob, J., Buluwela, L., Jiao, L. R., Periyasamy, M., Madsen, C. D., Caley, M. P., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt245 · Cited by 117
Kłysik, J., Theroux, S. J., Sedivy, J. M., Moffit, J. S., & Boekelheide, K. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.003 · Cited by 112
Manipulating the chemokine‐chemokine receptor network to treat cancer
Ruffini, P. A., Morandi, P., Cabıoğlu, N., Altundağ, K., & Cristofanilli, M. (2007) · Cancer · doi:10.1002/cncr.22706 · Cited by 114
Huang, S., Wa, Q., Pan, J., Peng, X., Ren, D., Huang, Y., Chen, X., & Tang, Y. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0645-7 · Cited by 114
Pro-apoptotic role of NF-κB: Implications for cancer therapy
Radhakrishnan, S. K., & Kamalakaran, S. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.001 · Cited by 115
Bist, P., Leow, S., Phua, Q., Shu, S. L., Zhuang, Q.-S., Loh, W.-S., Nguyen, T., Zhou, J., Hooi, S. C., & Lim, L. H. K. (2011) · Oncogene · doi:10.1038/onc.2011.28 · Cited by 112
Tacchini, L., Ponti, C. D., Matteucci, E., Follis, R., & Desiderio, M. A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh227 · Cited by 112
RetractedmiR‐515‐5p controls cancer cell migration through MARK4 regulation
Pardo, O. E., Castellano, L., Munro, C. E., Hu, Y., Mauri, F. A., Krell, J., Lara, R., Pinho, F. G., Choudhury, T., Frampton, A. E., et al. (2016) · EMBO Reports · doi:10.15252/embr.201540970 · Cited by 111
Dessein, A., Stechly, L., Jonckheere, N., Dumont, P., Monté, D., Leteurtre, E., Truant, S., Pruvot, F., Figeac, M., Hebbar, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3828 · Cited by 111
Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-κB signaling
Yu, P., Liu, Q., Liu, K., Yagasaki, K., Wu, E., & Zhang, G. (2009) · Cytotechnology · doi:10.1007/s10616-009-9225-9 · Cited by 110
Wang, Z., Ma, Q., Liu, Q., Yu, H., Zhao, L., Shen, S., & Yao, J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604745 · Cited by 111
Wani, N. A., Nasser, M. W., Ahirwar, D. K., Zhao, H., Miao, Z., Shilo, K., & Ganju, R. K. (2014) · Breast Cancer Research · doi:10.1186/bcr3665 · Cited by 108
NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype
Oh, A., Pardo, M. R., Rodriguez, A., Yu, C., Nguyen, L., Liang, O. D., Chorzalska, A. D., & Dubielecka, P. M. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01207-z · Cited by 110
Mehta, S., Christopherson, K. W., Bhat‐Nakshatri, P., Goulet, R. J., Broxmeyer, H. E., Kopelovich, L., & Nakshatri, H. (2006) · Oncogene · doi:10.1038/sj.onc.1210120 · Cited by 109
Self-citationThe critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis
Gelmini, S., Mangoni, M., Serio, M., Romagnani, P., & Lazzeri, E. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349262 · Cited by 107
Mirisola, V., Zuccarino, A., Bachmeier, B. E., Sormani, M. P., Falter, J., Nerlich, M. L., & Pfeffer, U. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.026 · Cited by 107
Breast cancer brain metastasis: molecular mechanisms and directions for treatment
Pedrosa, R. M. S. M., Mustafa, D. A. M., Soffietti, R., & Kros, J. M. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy044 · Cited by 108
Oncogenic and Anti-apoptotic Activity of NF-κB in Human Thyroid Carcinomas
Pacifico, F., Mauro, C., Barone, C., Crescenzi, E., Mellone, S., Monaco, M., Chiappetta, G., Terrazzano, G., Liguoro, D., Vito, P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403492200 · Cited by 102
Liu, Y., Mayo, M. W., Nagji, A. S., Smith, P. W., Ramsey, C. S., Li, D., & Jones, D. R. (2011) · Oncogene · doi:10.1038/onc.2011.308 · Cited by 101
A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
Xiang, Z., Zhou, Z.-J., Xia, G.-K., Zhang, X.-H., Wei, Z.-W., Zhu, J.-T., Yu, J., WenYing, C. H. E. N., He, Y., Schwarz, R. E., et al. (2017) · Oncogene · doi:10.1038/onc.2017.108 · Cited by 97
Immunohistochemical characterization of subtypes of male breast carcinoma
Ge, Y., Sneige, N., Eltorky, M., Wang, Z., Lin, E., Gong, Y., & Guo, M. (2009) · Breast Cancer Research · doi:10.1186/bcr2258 · Cited by 96
RETRACTED: HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB
Maroni, P., Bendinelli, P., Matteucci, E., & Desiderio, M. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl129 · Cited by 96
RetractedNasser, M. W., Qamri, Z., Deol, Y. S., Smith, D. L., Shilo, K., Zou, X., & Ganju, R. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023901 · Cited by 99
CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance
Liu, R., Fan, M., Candas, D., Qin, L., Zhang, X., Eldridge, A., Zou, J. X., Zhang, T., Juma, S., Jin, C., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0017 · Cited by 99
Braeuer, S. J., Büneker, C. K., Mohr, A., & Zwacka, R. M. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0231 · Cited by 92
Phyto-polyphenols as potential inhibitors of breast cancer metastasis
Avtanski, D. B., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0032-7 · Cited by 91
The Role of Plasmacytoid Dendritic Cells in Cancers
Zhou, B., Lawrence, T., & Liang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749190 · Cited by 90
STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential
To, S. Q., Dmello, R. S., Richards, A. K., Ernst, M., & Chand, A. L. (2022) · Cancers · doi:10.3390/cancers14020429 · Cited by 93
Yadav, V. R., Sung, B., Prasad, S., Kannappan, R., Cho, S., Liu, M., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0669-3 · Cited by 88
Lerma, E., Peiró, G., y Cajal, T. R., Fernandez, S., Martínez, D., Pons, C., Muñoz, F., Sabaté, J. M., Alonso, C., Ojeda, B., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800961 · Cited by 88
Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-κB Activation
Li, L., Zhao, F., Lü, J., Li, T., Yang, H., Wu, C., & Liu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095912 · Cited by 88
RetractedHayashi, H., & Kume, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.183 · Cited by 88
Xu, Q., Wang, Z., Chen, X., Duan, W., Lei, J., Zong, L., Li, X., Sheng, L., Ma, J., Han, L., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3069 · Cited by 90
Nomura, A., Majumder, K., Giri, B., Dauer, P., Dudeja, V., Roy, S., Banerjee, S., & Saluja, A. K. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.109 · Cited by 86
Tumor metabolism, cancer cell transporters, and microenvironmental resistance
Alfarouk, K. O. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1140753 · Cited by 88
Yang, X., Liu, D., Murray, T. J., Mitchell, G. C., Hestermann, E. V., Karchner, S. I., Merson, R. R., Hahn, M. E., & Sherr, D. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208938 · Cited by 86
The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
Zielińska, K. A., & Katanaev, V. L. (2020) · Cancers · doi:10.3390/cancers12103071 · Cited by 85
The good and bad faces of the CXCR4 chemokine receptor
Teixidó, J., Martínez‐Moreno, M., Díaz‐Martínez, M., & Sevilla‐Movilla, S. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.018 · Cited by 92
Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemia
Roccaro, A. M., Leleu, X. P., Sacco, A., Jia, X., Melhem, M. R., Moreau, A., Ngo, H. T., Runnels, J. M., Azab, A., Azab, F., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120972 · Cited by 82
Inhibition of CXCR4-Mediated Breast Cancer Metastasis: A Potential Role for Heparinoids?
Harvey, J., Mellor, P., Eldaly, H., Lennard, T. W. J., Kirby, J. A., & Ali, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1987 · Cited by 82
Goichberg, P., Kalinkovich, A., Borodovsky, N., Tesio, M., Petit, I., Nagler, A., Hardan, I., & Lapidot, T. (2005) · Blood · doi:10.1182/blood-2005-03-0941 · Cited by 81
Arya, M., Ahmed, H. U., Silhi, N., Williamson, M. P., & Patel, H. (2007) · Tumor Biology · doi:10.1159/000102979 · Cited by 84
Cabıoğlu, N., Şahin, A. A., Morandi, P., Meric‐Bernstam, F., Islam, R., Lin, H. Y., Bucana, C. D., Gonzalez-Angulo, A. M., Hortobágyi, G. N., & Cristofanilli, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn740 · Cited by 80
Wang, L., Wu, X., Shi, T., & Luo, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458141 · Cited by 80
Yasuoka, H., Tsujimoto, M., Yoshidome, K., Nakahara, M., Kodama, R., Sanke, T., & Nakamura, Y. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-340 · Cited by 78
Interleukin-1α Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer
Kumar, S., Kishimoto, H., Chua, H. L., Badve, S., Miller, K. D., Bigsby, R. M., & Nakshatri, H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63608-5 · Cited by 78
Self-citationHigh-level expression of functional chemokine receptor CXCR4 on human neural precursor cells
Ni, H. T., Hu, S., Sheng, W. S., Olson, J. M., Cheeran, M. C. ‐., Chan, A. S. H., Lokensgard, J. R., & Peterson, P. K. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.06.015 · Cited by 78
Tarnowski, M., Grymuła, K., Reca, R., Jankowski, K., Maksym, R., Tarnowska, J., Przybylski, G. K., Barr, F. G., Kucia, M., & Ratajczak, M. Z. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0259 · Cited by 78
Suyama, T., Furuya, M., Nishiyama, M., Kasuya, Y., Kimura, S., Ichikawa, T., Ueda, T., Nikaido, T., Itô, H., & Ishikura, H. (2004) · Cancer · doi:10.1002/cncr.20747 · Cited by 79
Arora, R., Yates, C. C., Gary, B. D., McClellan, S. B., Tan, M., Xi, Y., Reed, E., Piazza, G. A., Owen, L. B., & Dean-Colomb, W. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098370 · Cited by 77
RetractedBcl3 Selectively Promotes Metastasis of ERBB2-Driven Mammary Tumors
Wakefield, A., Soukupová, J., Montagne, A., Ranger, J. J., French, R., Muller, W. J., & Clarkson, R. W. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1321 · Cited by 77
miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer
Jiang, L., Yu, L., Zhang, X., Lei, F., Wang, L., Liu, X., Wu, S., Zhu, J., Wu, G., Cao, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1770 · Cited by 76
Shanmugam, R., Kusumanchi, P., Appaiah, H. N., Liang Cheng, C., Crooks, P. A., Neelakantan, S., Peat, T. J., Klaunig, J. E., Matthews, W., Nakshatri, H., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25587 · Cited by 75
Self-citationKim, M. J., Kim, W., Kim, D., Byun, J.-E., Huy, H., Lee, S.-Y., Song, H., Park, Y.-J., Kim, T.-D., Yoon, S., et al. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.03.007 · Cited by 63
Huang, X., Guo, B., Liu, S., Wan, J., & Broxmeyer, H. E. (2018) · Nature Communications · doi:10.1038/s41467-018-05178-5 · Cited by 76
Self-citationPET imaging of CXCR4 using copper-64 labeled peptide antagonist
Jacobson, O., Weiss, I. D., Szajek, L. P., Niu, G., Ma, Y., Kiesewetter, D. O., Farber, J. M., & Chen, X. S. (2011) · Theranostics · doi:10.7150/thno/v01p0251 · Cited by 76
Sukumaran, B. O., Ramadas, K., Sebastian, P., & Pillai, M. R. (2006) · Head & Neck · doi:10.1002/hed.20437 · Cited by 75
CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia
Schmid, B. C., Rudas, M., Rezniczek, G. A., Leodolter, S., & Zeillinger, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000019962.18922.87 · Cited by 73
CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma
Zhao, B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i19.2389 · Cited by 72
Colavito, S. A., Zou, M. R., Yan, Q., Nguyen, D. X., & Stern, D. F. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0444-4 · Cited by 71
Overexpression of CXCR4 Increases Migration and Proliferation of Human Adipose Tissue Stromal Cells
Cho, H. H., Kyoung, K. M., Seo, M. J., Kim, Y. J., Bae, Y. C., & Jung, J. S. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.853 · Cited by 71
Manu, K. A., Shanmugam, M. K., Ong, T. H., Subramaniam, A., Siveen, K. S., Perumal, E., Samy, R. P., Bist, P., Lim, L. H. K., Kumar, A. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057015 · Cited by 72
O’Malley, G., Heijltjes, M. T., Houston, A. M., Rani, S., Ritter, T., Egan, L. J., & Ryan, A. E. (2016) · Oncotarget · doi:10.18632/oncotarget.11354 · Cited by 72
Opdenakker, G., & Damme, J. V. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041796go · Cited by 71
Hu, J., Deng, X., Bian, X., Li, G., Tong, Y., Li, Y., Wang, Q., Xin, R., He, X., Zhou, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1798 · Cited by 70
Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells
Sierra, M. D. L. L., Gasperini, P., McCormick, P. J., Zhu, J., & Tosato, G. (2007) · Blood · doi:10.1182/blood-2007-03-081448 · Cited by 69
Rahman, K. W., Sarkar, F. H., Banerjee, S., Wang, Z. P., Liao, D. J., Hong, X., & Sarkar, N. H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0221 · Cited by 69
RetractedAltenburg, J. D., & Siddiqui, R. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0385 · Cited by 67
Wu, Q., Shao, H., Eton, D., Li, J., Li, J., Yang, B., Webster, K. A., & Yu, H. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00691.x · Cited by 67
Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CT
Nimmagadda, S., Pullambhatla, M., & Pomper, M. G. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.061325 · Cited by 67
Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway
Lee, C., Lee, M., Yoo, S.-M., Choi, K.-I., Song, J.-H., Jang, J., Oh, S., Ryu, H. W., Lee, H.-S., Surh, Y., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1580-7 · Cited by 65
Metadata
- Authors
- Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H.
- Affiliations
- Indiana University Indianapolis (US)
- Walther Cancer Foundation (US)
- Corresponding author
- Nakshatri, Harikrishna
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21631-21638
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980790180
- Cited by
- 639
- References
- 42
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 12 · 2022: 19 · 2021: 14 · 2020: 23 · 2019: 18 · 2018: 33 · 2017: 28 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 42 · 2012: 18
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health (5r21ca082208-02)
- National Heart, Lung, and Blood Institute (HL67384, R01HL067384)
- National Cancer Institute (CA82208)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053674, DK53674, T32DK007519)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- NF-κB, breast cancer, metastasis, cell migration, CXCR4, chemokine receptors, SDF-1α, chemokine signaling, IκB, transcriptional regulation, lung metastasis
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Chemotaxis, Flow Cytometry, Genetic Vectors, Humans, Neoplasm Metastasis, Neoplasm Transplantation, Plasmids, Promoter Regions, Genetic, Ribonucleases, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Up-Regulation, Gene Expression Regulation, Neoplastic, NF-kappa B, DNA, Complementary, COS Cells, Receptors, CXCR4, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, Transcription Factor RelA, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review